Parkinson's Trial NCT03887663
Track Parkinson progression in China
- Trial ID
- NCT03887663
- Official Title
- The Chinese Parkinson's Disease Registry
- Goal
- Track Parkinson progression in China
- Status
- RECRUITING
- Sponsor
- Xiangya Hospital of Central South University
- Study Type
- OBSERVATIONAL
- Enrollment
- 3000 participants
- Conditions
- Parkinson Disease
Summary For Families
The goal is to build a large database of people with Parkinson's in China so researchers can better understand how the disease progresses, which symptoms and treatments affect quality of life, and what factors predict different outcomes. It is an observational registry, not testing any experimental treatments, and it collects clinical information, medical history, medications and follow-up outcomes that researchers can use to study natural history and plan future trials. Adults of any age and sex with Parkinson's diagnosed by UK Brain Bank criteria can join, people who cannot give informed consent are excluded, and the project aims to enroll about 3,000 participants.
Locations
- Xiangya Hospital of Central South University, Changzhi, Hunan, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to build a large database of people with Parkinson's in China so researchers can better understand how the disease progresses, which symptoms and treatments affect quality of life, and what factors predict different outcomes. It is an observational registry, not testing any experimental treatments, and it collects clinical information, medical history, medications and follow-up outcomes that researchers can use to study natural history and plan future trials. Adults of any age and sex with Parkinson's diagnosed by UK Brain Bank criteria can join, people who cannot give informed consent are excluded, and the project aims to enroll about 3,000 participants.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 10 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- How many visits does this trial involve?
- Visits occur at baseline and at 12±1 months.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive); Walking & movement tests (non-invasive); Thinking & memory tests (non-invasive); MRI scan (non-invasive). Confirm the full schedule with the study coordinator.